Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Gwendoline Van GoietsenovenVéronique Mathieu

Abstract

Melanomas display poor response rates to adjuvant therapies because of their intrinsic resistance to proapoptotic stimuli. This study indicates that such resistance can be overcome, at least partly, through the targeting of eEF1A elongation factor with narciclasine, an Amaryllidaceae isocarbostyril controlling plant growth. Narciclasine displays IC(50) growth inhibitory values between 30-100 nM in melanoma cell lines, irrespective of their levels of resistance to proapoptotic stimuli. Normal noncancerous cell lines are much less affected. At nontoxic doses, narciclasine also significantly improves (P=0.004) the survival of mice bearing metastatic apoptosis-resistant melanoma xenografts in their brain. The eEF1A targeting with narciclasine (50 nM) leads to 1) marked actin cytoskeleton disorganization, resulting in cytokinesis impairment, and 2) protein synthesis impairment (elongation and initiation steps), whereas apoptosis is induced at higher doses only (≥200 nM). In addition to molecular docking validation and identification of potential binding sites, we biochemically confirmed that narciclasine directly binds to human recombinant and yeast-purified eEF1A in a nanomolar range, but not to actin or elongation factor 2, and th...Continue Reading

References

Nov 1, 1986·Journal of Natural Products·G R PettitY Sagawa
Mar 28, 1997·International Journal of Cancer. Journal International Du Cancer·W BergerM Micksche
Jun 6, 2003·Oncogene·María S Soengas, Scott W Lowe
Jun 6, 2003·Oncogene·Vladimir N IvanovZe'ev Ronai
Nov 25, 2003·Nature Cell Biology·Boon Tin ChuaPeng Li
Mar 24, 2004·Current Opinion in Cell Biology·Miguel López de Heredia, Ralf-Peter Jansen
May 5, 2005·Current Treatment Options in Oncology·Ehab Atallah, Lawrence Flaherty
May 24, 2005·Apoptosis : an International Journal on Programmed Cell Death·A McLachlanS Pandey
Jul 12, 2005·Toxicology and Applied Pharmacology·Caroline HayotChristine Decaestecker
Aug 24, 2005·Nature Structural & Molecular Biology·Stephane R Gross, Terri Goss Kinzy
Apr 21, 2006·Biochimica Et Biophysica Acta·Istvan R Boldogh, Liza A Pon
Dec 21, 2006·Molecular and Cellular Biology·Stephane R Gross, Terri Goss Kinzy
Feb 20, 2007·Current Medicinal Chemistry·Caterina A M La Porta
Mar 6, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J LiuW X Hu
Dec 7, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jürgen EberleLothar F Fecker
Dec 14, 2007·Cancer Treatment Reviews·Caroline HammUNKNOWN Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care
Jan 1, 2008·Gynecologic Oncology·Dixie E PinkeJonathan M Lee
Jan 24, 2008·Cellular and Molecular Life Sciences : CMLS·C G Noble, H Song
May 21, 2008·Chemical Reviews·Alexander Kornienko, Antonio Evidente
Jul 11, 2008·The Biochemical Journal·Vernonica E Franklin-Tong, Campbell W Gourlay
Aug 22, 2008·Journal of Cell Science·Changhui WangJeffrey Field
Oct 3, 2008·Cancer Letters·Xiao-shan LiuYing-mu Cai
Feb 27, 2009·Journal of Cellular and Molecular Medicine·Véronique MathieuRobert Kiss
Jun 18, 2009·Molecular Cancer Therapeutics·Florence LefrancRobert Kiss

❮ Previous
Next ❯

Citations

Jul 10, 2012·Journal of Medicinal Chemistry·Raphaël FrédérickJohan Wouters
Aug 19, 2011·The Journal of Biological Chemistry·Jyothsna VisweswaraiahEvelyn Sattlegger
Apr 11, 2014·BioMed Research International·Géraldine DescampsSven Saussez
Apr 8, 2011·Natural Product Reports·Zhong Jin
May 7, 2013·Natural Product Reports·Zhong Jin
Feb 2, 2012·Expert Review of Proteomics·Boris NegrutskiiAnna El'skaya
Mar 23, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Véronique MathieuPeter Proksch
Dec 23, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yongqiang TianMingquan Guo
Sep 12, 2012·Phytochemistry·Emmanuel Jean Teinkela MbossoRené Wintjens
Oct 22, 2011·Bioorganic & Medicinal Chemistry Letters·Laura CasuClaudia Sissi
Aug 4, 2011·Journal of Cellular and Molecular Medicine·Delphine Lamoral-TheysRobert Kiss
Aug 28, 2012·Bioorganic & Medicinal Chemistry Letters·Jerald J NairJohannes van Staden
Sep 3, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jerald J Nair, Johannes van Staden
Mar 28, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Na LiaoLongjiang Yu
Mar 22, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Daniela HulcováLucie Cahlíková
Dec 18, 2018·Natural Product Reports·Florence LefrancDavid Newman
Apr 25, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anna StarkRobert Fürst
Aug 31, 2019·EMBO Molecular Medicine·Andrea GrundJoerg Heineke
Apr 3, 2020·Scientific Reports·Ramakrishnan GopalakrishnanPreet M Chaudhary
Dec 20, 2018·Epigenomics·Katerina GrafanakiConstantinos Stathopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis